PHS
CELG

PFM Health Sciences’s Celgene Corp CELG Stock Holding History

PFM Health Sciences’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-159,895
Closed -$19.1M – 101
2015
Q4 		$19.1M Buy
+159,895
New +$18.5M 0.58% 47
2015
Q1 		– Sell
-482,322
Closed -$54M – 112
2014
Q4 		$54M Buy
482,322
+465,366
+2,745% +$49.1M 1.26% 27
2014
Q3 		$1.61M Buy
+16,956
New +$1.53M 0.04% 60

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PFM Health Sciences's CELG Position: Q1 2016 in Review

PFM Health Sciences sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 159,895 shares — an estimated $19.1M sold.

PFM Health Sciences first reported a position in CELG in Q3 2014 and held it in 3 quarters. The position peaked at $54M in Q4 2014. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • PFM Health Sciences reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
  • PFM Health Sciences sold 159,895 Celgene Corp shares in Q1 2016, an estimated $19.1M.
  • PFM Health Sciences first reported a position in Celgene Corp in Q3 2014 and held it in 3 quarters.
  • PFM Health Sciences's Celgene Corp position peaked at $54M in Q4 2014.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on PFM Health Sciences's 13F filing for Q1 2016, filed 16 May 2016.